Fibrinogen concentrate for bleeding in patients with congenital fibrinogen deficiency: Observational study of efficacy and safety for prophylaxis and treatment.
Joseph LaskyJerome TeitelMichael WangDanielle DaltonDirk Steffen SchmidtAndres BrainskyPublished in: Research and practice in thrombosis and haemostasis (2020)
In patients with CFD, FCH is a well-tolerated and effective treatment to achieve hemostasis during bleeding events and surgery and associated with infrequent bleeding events when used prophylactically.